Become a part of something bigger

Invest with Us

Become a part of something bigger

Invest with Us

Not only are we passionate about investing in healthcare and creating better options for patients around the world, but we are a team primarily composed of commercialization professionals. Our team has collectively helped invent, develop or launch over a hundred innovative and disruptive technologies in healthcare over the last 40 years. The clinical team has led global clinical trials and are leaders in their respective fields, authors and sought after lecturers.

When you bring people like this together under one company, you can expect great things to happen. We will remain on the cutting-edge of healthcare innovation and fully expect to commercialize promising devices, technologies and therapies that are safe, effective and serve the global healthcare market. Our passion for pursuing excellence will guarantee our success.

As a retired President of Medtronic International, the largest and most successful global medical device company, and a senior international executive for several major pharmaceutical companies (Pfizer, Bristol-Myers Squibb, Lederle/Wyeth), I had the privilege of living in 12 countries and doing business in more than 120. As a board member and advisor to private equity and venture capital firms focused on these markets, I can say, with confidence, that a new high growth market developing in healthcare is concierge medicine, or medical tourism, as evident by its 25% CAGR.

Leveraging the body’s ability to heal itself through internal and external mechanisms, such as stem cells, natural biologics, minimally invasive techniques and wearable technologies, is a key part of the future of medicine. These developments show great potential in the few areas of the world where they are authorized. However, most major developed countries have an antiquated and heavily bureaucratic regulatory system catering largely to big corporations and special interest groups. They have very little interest in seeing many of these new and unique technologies come to market. Consumers are becoming increasingly aware of these new trends and are looking for global options that meet their individual healthcare needs.

None of these emerging groups serving medical tourism have set high standards, but I firmly believe that Caribbean Healthcare Partners is uniquely poised to set the gold standard for this business. The group has recruited board members and advisors with very strong backgrounds and is committed to the highest ethical standards.

I have owned a home on Nevis for over 20 years and am very familiar with this lovely, twin-island federation, which is ideally suited to serve patients in North, Central and South America, the greater Caribbean and Western Europe. The selected location at Christophe Harbour is unique and will offer an unparalleled experience for visitors that will clearly set us apart.

Barry Wilson

Global Healthcare Advisor
Former President, Medtronic International
Former President, International of the Lederle Division of the American Cyanamid Company
Former President of Europe, Bristol-Meyers Squibb
Board of Directors, Bausch & Lomb
Chairman, Eucomed

INVESTORS

Investing Financial and Human Capital to Transform Healthcare and Build Lasting Value

Caribbean Healthcare Partners, Ltd. (“CHP” or the “Company”) is a privately-held healthcare real estate and development company incorporated under the laws of St. Kitts and Nevis in the Eastern Caribbean. Our investment philosophy is to identify segments of the healthcare industry that are ripe for disruption, align with our team’s strengths and meet our investment objectives.

We have initiated the first step in establishing a global brand of excellence in medical tourism through our flagship medical institute in Christophe Harbour, St. Kitts, W.I. Our team is focused on becoming the most trusted name and leading brand in this multi-billion-dollar industry that is estimated to grow between 25%-35% annually for the next 10 years. Our state-of-the-art, full service facility will serve discerning patients from North, Central and South America, Western Europe, as well as residents of St. Kitts & Nevis and the greater Caribbean. The medical institute is a wholly-owned subsidiary of CHP and consists of a real estate development company and medical operations company.

Interested in learning how you can invest with CHP?

Investing Financial and Human Capital to Transform Healthcare and Build Lasting Value

“I am so convinced I am right about this. There is a clear, major, opportunity to position St Kitts-Nevis as the most trusted & respected destination for medical tourism. Medical tourism is a $400 billion industry that is forecasted to grow at 25% per year for the next 10 years… St Kitts-Nevis is poised to capture this leadership position.”

Rowland Hanson

Former Vice President of Corporate Communications, Microsoft Corporation
Former Vice President of Worldwide Marketing, Neutrogena Corporation
Microsoft Alumni Foundation, Current Head of Strategic Partnerships
Santa Barbara, CA

“After exploring the option of medical tourism for over 10 years, the unique opportunities that St. Kitts offers made my decision to participate straightforward. I look forward, along with my international colleagues, in assisting patients with cutting-edge knee repair, restorative and preservation services. We are selecting these treatments from those approved by recognized regulatory bodies in countries with established track records for patient safety and product efficacy.
When discussing the work environment, patient care and treatments that will be available, over 25 world-recognized leaders in sports medicine and knee treatments have verbally committed to staffing the Knee and Sports Medicine department at the Institute.”

Jack Farr, MD

Co-Editor of “Cartilage Restoration: Practical Clinical Applications”
Member, Cartilage Research Foundation
Design Surgeon and Clinical Researcher
Indianapolis, IN

“There is a clear, major, opportunity to position St Kitts-Nevis as the most trusted & respected destination for medical tourism. Medical tourism is a $400 billion industry that is forecasted to grow at 25% per year for the next 10 years.”

Rowland Hanson

Former Vice President of Corporate Communications, Microsoft Corporation
Former Vice President of Worldwide Marketing, Neutrogena Corporation
Microsoft Alumni Foundation, Current Head of Strategic Partnerships
Santa Barbara, CA

“Over 25 world-recognized leaders in sports medicine and knee treatments have verbally committed to staffing the Knee and Sports Medicine department at the Institute.”

Jack Farr, MD

Co-Editor of “Cartilage Restoration: Practical Clinical Applications”
Member, Cartilage Research Foundation
Design Surgeon and Clinical Researcher
Indianapolis, IN